These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7623868)

  • 21. The utility of short-term tests for mutagenicity in the toxicological evaluation of environmental agents.
    De Serres FJ
    Mutat Res; 1975 Nov; 33(1 Spec No):11-5. PubMed ID: 1202333
    [No Abstract]   [Full Text] [Related]  

  • 22. A Return to the Origin of the EMGS: Rejuvenating the Quest for Human Germ Cell Mutagens and Determining the Risk to Future Generations.
    Marchetti F; Douglas GR; Yauk CL
    Environ Mol Mutagen; 2020 Jan; 61(1):42-54. PubMed ID: 31472026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of the dominant lethal test in the freshwater mollusk Biomphalaria glabrata (Say, 1818).
    Nakano E; Watanabe LC; Ohlweiler FP; Pereira CA; Kawano T
    Mutat Res; 2003 Apr; 536(1-2):145-54. PubMed ID: 12694755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of genetic toxicology data in U.S. EPA risk assessment: the mercury study report as an example.
    Schoeny R
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):663-73. PubMed ID: 8781402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs).
    MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V; Johnson GE
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():55-65. PubMed ID: 25953400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Commission for Protection against Environmental Mutagens and Carcinogens. Committee 2 Final Report. Mutagenesis testing as an approach to carcinogenesis.
    Mutat Res; 1982 Jul; 99(1):73-91. PubMed ID: 6214712
    [No Abstract]   [Full Text] [Related]  

  • 27. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
    McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
    Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short-term tests in the system of assessment of human carcinogens].
    Belitskiĭ GA; Khudoleĭ VV
    Vopr Onkol; 1986; 32(4):3-11. PubMed ID: 3518237
    [No Abstract]   [Full Text] [Related]  

  • 31. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.
    Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC
    Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937
    [No Abstract]   [Full Text] [Related]  

  • 32. Transgenic animal models for mutagenesis studies: role in mutagenesis research and regulatory testing.
    MacGregor JT
    Environ Mol Mutagen; 1998; 32(2):106-9. PubMed ID: 9776171
    [No Abstract]   [Full Text] [Related]  

  • 33. Critical assessment of the genetic toxicity of naphthalene.
    Brusick D
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S37-42. PubMed ID: 17980943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interpretation and analysis of cytogenetic data.
    Danford N
    Methods Mol Biol; 2012; 817():93-120. PubMed ID: 22147570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spermatogenesis and mutagenicity of environmental hazards: extrapolation of genetic risk from mouse to man.
    Adler ID
    Andrologia; 2000 Sep; 32(4-5):233-7. PubMed ID: 11021514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring relationships between mutagenic and carcinogenic potencies.
    Piegorsch WW; Hoel DG
    Mutat Res; 1988 Sep; 196(2):161-75. PubMed ID: 3419441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant lethal and heritable translocation tests with chlorambucil and melphalan in male mice.
    Generoso WM; Witt KL; Cain KT; Hughes L; Cacheiro NL; Lockhart AM; Shelby MD
    Mutat Res; 1995 Dec; 345(3-4):167-80. PubMed ID: 8552138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA damage and repair in somatic and germ cells in vivo.
    Vogel EW; Natarajan AT
    Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.